Pentagamavunon-1 is primarily investigated for its potential therapeutic applications, particularly in the field of oncology. It has shown promise as an anti-cancer agent due to its ability to inhibit the growth of cancer cells and induce apoptosis. The compound is also studied for its anti-inflammatory properties, making it a candidate for treating inflammatory diseases. Additionally, its antioxidant effects are being explored for potential use in protecting cells from oxidative stress-related damage. Research continues to evaluate its efficacy and safety in various medical applications.